Answers are grounded in this paper and cite their sources.
Demonstrates enhanced tumor response in immunotherapy, suggesting new treatment strategies.
Chemotherapy is still widely used for combating solid tumors, yet its bottleneck is often associated with off‐target toxicity and weak immune activation. Herein, we report a TME‐activatable nanoplatform based on MnO 2‐x to load graphene quantum dot (GQD/MnO 2‐x ) for tumor‐specific chemo‐immunotherapy. By comparing MnCl 2 ‐, MnF 3 ‐, and KMnO 4 ‐derived MnO 2‐x , we find that Mn(III)‐derived MnO 2‐x exhibits the highest O V content (27.2%) and GQD loading efficiency (61.35%). Specifically, coordination between pyrrolic N in GQDs and Mn 3+ suppresses Mn(III) disproportionation, promoting O V formation and improving GQD encapsulation. MnO 2‐x carrier passivates the DNA damage effect of GQDs against normal cells while undergoing GSH‐triggered degradation in tumors to release GQDs and Mn ions. Upon tumor‐specific disassembly, released GQDs bind the DNA major groove and induce DNA damage for improved chemotherapy. Concurrently, Mn 4+ ‐mediated GSH depletion promotes ferroptosis and reverses the immunosuppressive TME, whereas released Mn 2+ activates cGAS‐STING pathway to promote DC maturation and activate T cells. This cascade amplification of antitumor immune response mediated by GQD/MnO 2‐x achieves effective inhibition effect on the growth of primary and distant tumors without recurrence. Overall, this work highlights activity passivation engineering for the utilization of TME‐responsive nanoplatforms for tumor‐specific chemotherapy amplified immunotherapy through triggering ferroptosis and activating cGAS‐STING pathway.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: